Author: healthadmin

A study of misophonia patients found that about 65% had a diagnosis of at least one other mental illness. The most common additional diagnoses were depression (49%) and anxiety disorders (47%). The paper is psychiatric research. Misophonia is a condition characterized by intense emotional and physiological reactions to certain everyday sounds. Common trigger sounds include chewing, breathing, tapping, or repetitive clicking sounds. When people with misophonia are exposed to these triggers, they experience anger, disgust, anxiety, or the urge to flee. The reaction is usually immediate and disproportionate to the actual loudness or objective intensity of the sound. Research suggests…

Important points: A major German manufacturer has sent lawyers and lobbyists in and around Washington, D.C., to seek protection for the herbicide Roundup. The company’s actions clearly demonstrate its power and influence in protecting its best-selling pesticide. The opposition retaliates in court, on social media and in street protests. Let’s talk about America’s two-tier operating system and its impact on water and health. At the top are corporate executives who deploy teams of lawyers and lobbyists to influence government decisions in their favor. At the root of this are citizens relying on social media, noisy protests, and courts to carry…

WASHINGTON (AP) – A Virginia boater is suing a Washington water utility company for negligence over a leaking pipe that collapsed. Millions of gallons of untreated sewage Enter the Potomac River.The class action lawsuit, filed Friday in U.S. District Court in Greenbelt, Maryland, comes weeks after a sewer pipe collapsed in an area just north of Washington, D.C., in January, sending sewage from the ground into a river. The spill was considered a serious environmental disaster and resulted in extensive litigation. focus of political controversy The breach occurred between President Donald Trump and the Democratic-led state of Maryland. Plaintiff Dr.…

Issues at the former Catalent plant, now owned by Novo Nordisk, derailed another FDA application, Incyte announced Friday that the FDA has submitted a complete response letter (CRL) for its PD-1 inhibitor Zynyz as a first-line treatment for non-small cell lung cancer (NSCLC). The failure (PDF) was not due to efficacy or safety concerns, but was related to test results at a fill-finish facility, specifically the former Catalent plant in Bloomington, Indiana, which is now owned by Novo as part of Novo Holdings’ $16.5 billion acquisition of CDMO in 2024. This setback comes more than a year after Incyte detailed…

In a study of adults with advanced prostate cancer taking androgen receptor pathway inhibitors and various types of anticoagulants, researchers found no evidence that the patients were at increased risk of bleeding or clotting, despite previous test results raising alarms. The findings are published on Wiley Online. cancera peer-reviewed journal of the American Cancer Society. Thromboembolism, caused when a circulating blood clot becomes blocked and causes an occlusion, is the second leading cause of death in cancer patients, surpassed only by progression of the cancer itself. Anticoagulants (blood thinners) are standard therapy for the treatment or prevention of thromboembolism. Thromboembolism…

Ipsen is halting sales of its cancer drug Tazveric, which it acquired through its acquisition of Epizyme less than four years ago, after an independent data monitoring board flagged its safety in clinical trials. The move may not have a major impact on Ibsen’s financial performance, but it could shake confidence in the company’s business development acumen, at least one analyst group argues. Specifically, the Paris-based drugmaker is voluntarily withdrawing tazveric, also known as tazemetostat, from all indications and all markets, including the United States, where the company holds commercial rights to the EZH2 inhibitor, according to a March 9…

As the days begin to get longer again, Dr. Christine Bloom’s phone rings frequently. That’s because journalists want to ask sleep researchers what spring fatigue is. Up until now, she has always responded that no studies have investigated this phenomenon. “But I always felt that this was not enough,” says Bloom, a researcher at the University Psychiatric Clinic (UPK) and the Center for Chronobiology at the University of Basel. So she teamed up with Dr. Albrecht Forster, a sleep researcher at the University of Bern’s Inselspital, to conduct a study to find out whether people are actually more tired in…

In recent research, sleep research journal It suggests that people who frequently experience lucid dreams have specific physical network patterns in their brains. Scientists have discovered that our tendency to recognize that we are dreaming during sleep is linked to integrated brain structures responsible for self-awareness, mental imagery, and cognitive control. This provides evidence that lucid dreams are not simply temporary sleep states, but may reflect distinct physical organization of the brain. Lucid dreaming occurs when a person becomes aware that they are dreaming and may be able to direct the events of the dream. Previous studies using brain scans…

Kenya was shocked when she was diagnosed with multiple sclerosis (MS). Active and busy with church and friends, she knew how to juggle many things, but navigating a new chronic illness that affected her daily life created anxiety and fear. When Kenya visited Accredo® Specialty Pharmacy, part of Evernorth Health Services, she found more than just a pharmacy. Accredo has become a trusted partner in her health journey. As a specialty pharmacy, Accredo provides personalized care to patients with complex and chronic conditions. In addition to the medication she needs to treat her MS, Accredo provides Kenya with support and…

Get your daily dose of health and medicine every weekday with Morning Rounds, STAT’s free newsletter. Sign up here. Who needs March Madness when you can have STAT Madness? The second round of the annual competition celebrating innovation in science and medicine begins today. Please vote here. Prasad’s resignation creates new turmoil at FDA Vinay Prasad is leaving the Food and Drug Administration for the second time under the Trump administration after a tumultuous reign as director of the Center for Biological Evaluation and Research. (He was fired last July and rehired a few weeks later.) STAT’s Lizzie Lawrence has…